Maze Therapeutics Inc. (MAZE) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Maze Therapeutics Inc.

NASDAQ: MAZE · Real-Time Price · USD
27.11
0.61 (2.30%)
At close: Oct 03, 2025, 3:59 PM
27.11
0.00%
After-hours: Oct 03, 2025, 07:14 PM EDT

Maze Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
Cash & Equivalents
196.81M 29.16M 99.92M
Short-Term Investments
n/a n/a n/a
Long-Term Investments
1.09M 1.09M 1.21M
Other Long-Term Assets
7.87M 1.32M 1.37M
Receivables
n/a n/a n/a
Inventory
n/a n/a n/a
Other Current Assets
4.86M 4.95M 6.23M
Total Current Assets
201.67M 34.11M 106.15M
Property-Plant & Equipment
29.92M 34.98M 41.23M
Goodwill & Intangibles
n/a n/a n/a
Total Long-Term Assets
38.87M 37.39M 43.81M
Total Assets
240.54M 71.5M 149.96M
Account Payables
1.94M 2.02M 1.58M
Deferred Revenue
n/a n/a n/a
Short-Term Debt
4.63M 4.49M 4.32M
Other Current Liabilities
1.39M 2.39M 3.06M
Total Current Liabilities
20.67M 16.32M 20.78M
Long-Term Debt
n/a 20.08M n/a
Other Long-Term Liabilities
509.06M 383.9M 383.9M
Total Long-Term Liabilities
531.05M 429.04M 411.63M
Total Liabilities
551.73M 445.35M 432.42M
Total Debt
26.63M 49.62M 32.05M
Book Value
-311.18M -373.85M -282.46M
Book Value Per Share
-7.11 -8.54 -6.45
Common Stock
2K 2K 2K
Retained Earnings
-358.43M -395.69M -295.27M
Comprehensive Income
n/a n/a n/a
Shareholders Equity
-311.18M -373.85M -282.46M
Total Investments
1.09M 1.09M 1.21M